Emilio Gonzalez, MD

Director, Rheumatology Fellowship Program

Professor, Internal Medicine

Emailebgonzal@utmb.edu

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Emilio Gonzalez is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

20 Completed

Protocol N1071F2: "A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade (Infliximab) for the Treatment of Patients with Rheumatoid Arthritis"
Gonzalez, E.
Inventiv Health Clinical
3/6/17 → 3/5/19
Project: Other project
Protocol N1071F2: "A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade (Infliximab) for the Treatment of Patients with Rheumatoid Arthritis"
Gonzalez, E.
3/6/17 → 3/5/19
Project: Other project
Protocol EMR700461-024: A Phase IIB, Multi-Center, Long-Term Extension Trial to Evaluate the Safety and Tolerability of Atacicept in Subjects with Systemic Lupus Erythematosus (SLE) who Completed Protocol EMR-700461-023 (ADDRESS II)
Gonzalez, E.
EMD Serono Inc
8/26/14 → 8/25/16
Project: Other project
Protocol EMR700461-024: A Phase IIB, Multi-Center, Long-Term Extension Trial to Evaluate the Safety and Tolerability of Atacicept in Subjects with Systemic Lupus Erythematosus (SLE) who Completed Protocol EMR-700461-023 (ADDRESS II)
Gonzalez, E.
8/26/14 → 8/25/16
Project: Other project
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Gonzalez, E.
7/28/14 → 7/27/16
Project: Other project

1471 Citations
24 h-Index
57 Article
9 Review article
7 Letter
4 Comment/debate
1 More
- 1 Chapter

Oral administration of Domain-I of beta-2glycoprotein-I induces immunological tolerance in experimental murine antiphospholipid syndrome
Shemer, A., Willis, R., Gonzalez, E., Romay-Penabad, Z., Shovman, O., Shoenfeld, Y., Blank, M. & Amital, H., May 1 2019, In : Journal of Autoimmunity. 99, p. 98-103 6 p.
Research output: Contribution to journal › Article › peer-review
5 Scopus citations
The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort
Radin, M., Sciascia, S., Erkan, D., Pengo, V., Tektonidou, M. G., Ugarte, A., Meroni, P., Ji, L., Belmont, H. M., Cohen, H., Ramires de Jesús, G., Branch, D. W., Fortin, P. R., Andreoli, L., Petri, M., Rodriguez, E., Rodriguez-Pinto, I., Knight, J. S., Atsumi, T., Willis, R. & 11 others, Gonzalez, E., Lopez-Pedrera, R., Rossi Gandara, A. P., Borges Gualhardo Vendramini, M., Banzato, A., Sevim, E., Barbhaiya, M., Efthymiou, M., Mackie, I., Bertolaccini, M. L. & Andrade, D., Dec 2019, In : Seminars in Arthritis and Rheumatism. 49, 3, p. 464-468 5 p.
Research output: Contribution to journal › Article › peer-review
9 Scopus citations
Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease
Erkan, D., Unlu, O., Sciascia, S., Belmont, H. M., Branch, D. W., Cuadrado, M. J., Gonzalez, E., Knight, J. S., Uthman, I., Willis, R., Zhang, Z., Wahl, D., Zuily, S. & Tektonidou, M. G., Mar 1 2018, In : Lupus. 27, 3, p. 399-406 8 p.
Research output: Contribution to journal › Article › peer-review
24 Scopus citations
PEGylated Domain I of Beta-2-Glycoprotein I inhibits the binding coagulopathic, and thrombogenic properties of IgG From patients with the antiphospholipid syndrome
McDonnell, T. C. R., Willis, R., Pericleous, C., Ripoll, V. M., Giles, I. P., Isenberg, D. A., Brasier, A. R., Gonzalez, E. B., Papalardo, E., Romay-Penabad, Z., Jamaluddin, M., Ioannou, Y. & Rahman, A., Oct 22 2018, In : Frontiers in immunology. 9, OCT, 2413.
Research output: Contribution to journal › Article › peer-review
4 Scopus citations
Performance Evaluation and Clinical Associations of Immunoassays That Detect Antibodies to Negatively Charged Phospholipids Other Than Cardiolipin
Castanon, A., Pierre, G., Willis, R., Nigel Harris, E., Papalardo, E., Romay-Penabad, Z., Schleh, A., Jajoria, P., Smikle, M., Deceulaer, K., Tebo, A., Jaskowski, T., Guerra, M. M., Ware Branch, D., Salmon, J. E., Petri, M. & Gonzalez, E. B., Mar 29 2018, In : American journal of clinical pathology. 149, 5, p. 401-411 11 p.
Research output: Contribution to journal › Article › peer-review
7 Scopus citations